Bliss GVS Pharma Announces Book Closure and Record Dates for 41st AGM and Final Dividend
Bliss GVS Pharma Limited has announced key dates related to its forthcoming 41st Annual General Meeting (AGM) and the payment of the final dividend for the financial year ended March 31, 2026. The company designated a period for book closure to determine the members' records for both events.The Register of Members and Share Transfer Books of Bliss GVS Pharma Limited will be closed from Thursday, July 09, 2026, through Wednesday, July 15, 2026. This window is designated for identifying shareholders who will participate in the 41st Annual General Meeting, which is scheduled to take place on Wednesday, July 15, 2026.
The company also provided specific record dates pertaining to its stock exchanges for these events.
| Stock Exchange | Security Code/Symbol | Type of Security | Book Closure Period | Record Date (for dividend) | Purpose |
|---|---|---|---|---|---|
| BSE Limited | 506197 | Equity Shares | July 09 to July 15, 2026 | July 08, 2026 | 41st Annual General Meeting |
| National Stock Exchange of India (NSE) | BLISSGVS | Equity Shares | July 09 to July 15, 2026 | N/A | 41st AGM and Final Dividend Payment for FY ended March 31, 2026 |
The final dividend payment is slated to occur on or before Friday, August 14, 2026, provided it receives approval from the Members during the ensuing 41st AGM.
This corporate action addresses both shareholder meeting requirements and dividend distribution related to the financial year ended March 31, 2026.
BLISSGVS Stock Price Movement
Bliss GVS Pharma Limited shares today slipped by 0.78% to settle at ₹469.55, closing lower from previous trading levels. The stock saw significant intraday volatility, trading within a range defined by a high of ₹477 and a low of ₹455.4.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.